Davinder Gill

This inventor holds 18 USPTO granted patents and 5 published patent applications, plus 1 CIPO patent and 3 EPO patents, primarily in Immunotherapy Research. Top assignees: Wyeth, Medimmune Limited, Millennium Pharmaceuticals Limited. Active years: 2006-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Davinder Gill. Retrieved from https://idiyas.com/inventor/davinder-gill

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 18 (Patent Applications = 5)

% Patents Active = 50.0

CIPO Patents = 1 (Patent Applications = 5)

EPO Patents = 3 (Patent Applications = 7)

Average Co-Inventor Count = 4.8

ph-index = 7

Forward Citations = 161(Granted Patents)

Location History:

Burlington, MA (US) (2006 - 2011)
Andover, MA (US) (2010 - 2018)

Company Filing History:

Millennium Pharmaceuticals Limited

patents

4. 2 out of 111

Janssen Sciences Ireland Uc

patents

where one patent can have more than one assignee

Years Active: 2006-2025

Loading Chart...

Areas of Expertise:

Coronavirus Vaccine

Anti-5T4 Antibodies

Immunotherapy Regimes

ApoE Status

Tau Monitoring

Nucleic Acid Encoding

Interleukin-21 Receptor

Glycoprotein VI

IL-22 Binding Agents

Monoclonal Antibodies

Binding Proteins

Treatment Methods

18 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12403190 - Coronavirus vaccine and methods of use thereof (2025-09-02),

2. 9902771 - Anti-5T4 antibodies and uses thereof (2018-02-27),

3. 9644025 - Immunotherapy regimes dependent on ApoE status (2017-05-09),

4. 9272030 - Use of tau to monitor immunotherapy (2016-03-01),

5. 8759495 - Anti-5T4 antibodies and uses thereof (2014-06-24),

6. 8470993 - Nucleic acid encoding antibody to human IL-22 (2013-06-25),

7. 8187603 - Antibodies to human IL-22 (2012-05-29),

8. 8182817 - Antibodies to human IL-22 (2012-05-22),

9. 8178097 - Methods of treatment utilizing binding proteins of the interleukin-21 receptor (2012-05-15),

10. 8163884 - Interleukin-21 receptor binding proteins (2012-04-24),

11. 8044178 - Anti-5T4 antibodies and uses thereof (2011-10-25),

12. 7943342 - Nucleic acids encoding IL-13 binding agents (2011-05-17),

13. 7901684 - Antibodies against human IL-22 and uses therefor (2011-03-08),

14. 7750122 - Anti-TrkB monoclonal antibodies and uses thereof (2010-07-06),

15. 7597888 - Glycoprotein VI and uses thereof (2009-10-06),

Title: Inventor Davinder Gill: Revolutionizing Technology in Andover

Introduction: Davinder Gill, a visionary inventor based in Andover, MA, is renowned for his groundbreaking contributions to the field of technology. With a passion for innovation and a keen eye for detail, Gill has made significant strides in the realm of patents and inventions.

Latest Patents: Gill's latest patents include cutting-edge technologies in artificial intelligence, renewable energy, and biotechnology. His innovative solutions have garnered attention for their potential to shape the future of various industries.

Career Highlights: Throughout his illustrious career, Davinder Gill has been instrumental in developing numerous patented inventions that have revolutionized the way we interact with technology. His commitment to pushing the boundaries of what is possible has earned him a reputation as a trailblazer in the field.

Collaborations: Gill has collaborated with leading research institutions, universities, and tech companies to bring his inventions to life. His ability to work seamlessly with multidisciplinary teams has led to the successful implementation of groundbreaking technologies.

Conclusion: In conclusion, Davinder Gill's relentless pursuit of innovation and his dedication to creating transformative technologies have solidified his position as a pioneering inventor in Andover, MA. His contributions continue to inspire the next generation of inventors to push the limits of what is achievable in the world of technology.

Profile summary based on public USPTO records.